Sergei Tjulandin Selected Research

Sergei Tjulandin Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 11/2005
17	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2005
5	Adenocarcinoma 07/2022 - 08/2007
5	Neutropenia 02/2019 - 11/2005
4	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 05/2014
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2018 - 06/2004
3	Disease Progression 01/2023 - 01/2012
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 11/2006
3	Seminoma 07/2015 - 03/2008
3	Neoplasm Metastasis (Metastasis) 05/2015 - 10/2007
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 01/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 11/2017
2	Diarrhea 07/2022 - 05/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 01/2016
2	Necrosis 01/2017 - 10/2012
2	Pathologic Complete Response 04/2016 - 01/2014
2	Heart Failure 03/2010 - 11/2009
2	Pain (Aches) 01/2010 - 08/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Nonseminomatous germ cell tumor 09/2018
1	Fatigue 11/2017
1	Ovarian Epithelial Carcinoma 01/2017
1	Carcinoma (Carcinomatosis) 07/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Triple Negative Breast Neoplasms 01/2016
1	Exanthema (Rash) 05/2015
1	Asthenia 12/2014
1	Nausea 12/2014
1	Esophageal Neoplasms (Esophageal Cancer) 09/2014
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2014
1	Infections 05/2014
1	Inflammatory Breast Neoplasms 05/2014
1	Thrombosis (Thrombus) 05/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2014

Drug/Important Bio-Agent (IBA)

9	Trastuzumab (Herceptin)FDA Link 01/2021 - 11/2009
9	ErbB Receptors (EGF Receptor)IBA 10/2020 - 11/2009
6	Paclitaxel (Taxol)FDA LinkGeneric 07/2022 - 11/2005
6	Docetaxel (Taxotere)FDA Link 10/2011 - 11/2006
5	Lapatinib (GW572016)FDA Link 01/2021 - 01/2010
5	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 11/2006
5	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 11/2006
4	alofanibIBA 01/2023 - 01/2016
4	human ERBB2 proteinIBA 01/2021 - 11/2009
3	Hormones (Hormone)IBA 01/2021 - 11/2009
3	Panitumumab (Vectibix)FDA Link 10/2020 - 05/2014
3	AntibodiesIBA 10/2020 - 06/2004
3	Cetuximab (Erbitux)FDA Link 10/2020 - 05/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014 - 03/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 01/2010
2	lenvatinibIBA 01/2024 - 01/2023
2	pembrolizumabIBA 01/2024 - 01/2023
2	Sunitinib (Sutent)FDA Link 01/2024 - 01/2023
2	Aromatase InhibitorsIBA 01/2021 - 10/2018
2	Monoclonal AntibodiesIBA 10/2020 - 05/2014
2	PlatinumIBA 01/2020 - 01/2017
2	Biosimilar PharmaceuticalsIBA 02/2019 - 01/2010
2	Tumor Biomarkers (Tumor Markers)IBA 09/2018 - 09/2014
2	Capecitabine (Xeloda)FDA Link 11/2017 - 01/2012
2	Epirubicin (Ellence)FDA LinkGeneric 11/2017 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 10/2007
2	Bevacizumab (Avastin)FDA Link 11/2016 - 01/2012
2	taxaneIBA 05/2015 - 12/2014
2	Taxoids (Taxanes)IBA 05/2015 - 12/2014
2	Albumin-Bound Paclitaxel FDA Link 10/2011 - 11/2005
2	SolventsIBA 10/2011 - 11/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	napabucasinIBA 07/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	pegfilgrastim (Neulasta)FDA Link 02/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	LigandsIBA 11/2017
1	rilotumumabIBA 11/2017
1	Cytotoxins (Cytolysins)IBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 04/2016
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2015
1	P 11 (P-11)IBA 05/2015
1	AnthracyclinesIBA 12/2014
1	TrabectedinIBA 12/2014
1	Alanine Transaminase (SGPT)IBA 12/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	Methotrexate (Mexate)FDA LinkGeneric 01/2014

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 01/2020 - 09/2005
16	Therapeutics 01/2023 - 06/2004
3	Neoadjuvant Therapy 09/2014 - 02/2009
2	Radiotherapy 01/2020 - 10/2007
2	Orchiectomy (Orchidectomy) 01/2014 - 05/2013
2	Induction Chemotherapy 05/2013 - 10/2007
1	Cystectomy 10/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2017
1	Maintenance Chemotherapy 01/2015
1	Precision Medicine 09/2014
1	Combined Modality Therapy 09/2014